mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.28 |
7e-06 |